Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1133041

	registered interest
	date	18/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Yellow Card Scheme
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what steps they are taking to (1) encourage pharmacists and clinicians to make full use of the Yellow Card Scheme to report adverse drug reaction to the Medicines and Healthcare products Regulatory Agency, and (2) improve direct patient access to the scheme and to seek patients views on it.
	tabling member printed	Baroness Finlay of Llandaff
	uin	HL16459
	answer	answer is ministerial correction date of answer 27/06/2019 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) has a strategy to improve engagement with the Yellow Card Scheme as well as to increase access through a wide variety or reporting mechanisms, for both healthcare professionals as well as for patients.</p><p>The MHRA has expanded the mechanisms through which reports of side effects can be made. Most recently a new mobile reporting application was delivered, which also includes helpful information about medicines. The MHRA is also continuing to integrate with clinical systems within primary and secondary care to make reporting faster and more accessible to healthcare professionals which has already driven reporting rates up and will continue to do so with the inclusion of more clinical systems.</p><p>The MHRA actively promote the Scheme through regular awareness campaigns (both locally and internationally), attendance at conferences and patient groups, satellite Yellow Card centres that promote locally and the MHRA also provides a range of educational materials to support understanding of the Scheme and the work that the MHRA does.</p><p>An important mechanism to maximise use of the Scheme by healthcare professionals and increase its impact is the National Medication Safety Network, which consists of approximately 450 Medication Safety Officers (MSOs), who raise awareness for reporting of side effects due to medication errors. MSOs are mostly pharmacists based within hospital trusts who encourage local and national learning as well as improve reporting.</p><p>The MHRA regularly communicates safety information through a monthly electronic newsletter called Drug Safety Update which informs healthcare professionals about the latest medicines safety issues and is always coupled with messages to report suspected adverse drug reactions to the Yellow Card Scheme.</p><p>To improve accessibility and transparency, the MHRA has publicly available online interactive Drug Analysis Profiles (iDAPs). The iDAPs are provided for all licensed drugs for which the MHRA have received reports of suspected adverse reactions through the Yellow Card Scheme.</p><p>The MHRA encourages online feedback from both healthcare professionals and patients and proactively engages with patients on a regular basis. Feedback from patients is used to make improvements to the Scheme and to the ways in which patients can report suspected side effects.</p> answering member printed Baroness Blackwood of North Oxford question first answered 27/06/2019 13:36:32 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	3609 label Biography information for Baroness Finlay of Llandaff

1127265

	registered interest
	date	16/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	West Hertfordshire Hospitals NHS Trust: Finance
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how much funding they provided to the West Hertfordshire Hospitals NHS Trust in each year from May 2010 to May 2015.
	tabling member printed	Baroness Thornhill
	uin	HL15818
	answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>The Department does not hold the information requested on funding which was changed, cancelled or forfeited in each year from May 2010 to May 2015.</p><p>The following table shows the total amount of income that West Hertfordshire Hospitals NHS Trust received in the financial years 2011-12 to 2014-15.</p><table><tbody><tr><td><p>Year</p></td><td><p>Income £ million</p></td></tr><tr><td><p>2011-12</p></td><td><p>273.7</p></td></tr><tr><td><p>2012-13</p></td><td><p>278.2</p></td></tr><tr><td><p>2013-14</p></td><td><p>291.34</p></td></tr><tr><td><p>2014-15</p></td><td><p>344.97</p></td></tr></tbody></table><p> </p><p>We are not able to divide the income into years from May to April due to how the data is reported, which is by financial year. Additionally, this is total income, so it includes Government funding plus any additional funding that the trust received.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL15819 question first answered 24/05/2019 11:48:46 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	4558 label Biography information for Baroness Thornhill

1127266

	registered interest
	date	16/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	West Hertfordshire Hospitals NHS Trust: Finance
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what funding committed to the West Hertfordshire Hospitals NHS Trust from May 2005 to May 2010 was (1) changed, (2) cancelled, and (3) forfeit, in each year from May 2010 to May 2015.
	tabling member printed	Baroness Thornhill
	uin	HL15819
	answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>The Department does not hold the information requested on funding which was changed, cancelled or forfeited in each year from May 2010 to May 2015.</p><p>The following table shows the total amount of income that West Hertfordshire Hospitals NHS Trust received in the financial years 2011-12 to 2014-15.</p><table><tbody><tr><td><p>Year</p></td><td><p>Income £ million</p></td></tr><tr><td><p>2011-12</p></td><td><p>273.7</p></td></tr><tr><td><p>2012-13</p></td><td><p>278.2</p></td></tr><tr><td><p>2013-14</p></td><td><p>291.34</p></td></tr><tr><td><p>2014-15</p></td><td><p>344.97</p></td></tr></tbody></table><p> </p><p>We are not able to divide the income into years from May to April due to how the data is reported, which is by financial year. Additionally, this is total income, so it includes Government funding plus any additional funding that the trust received.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL15818 question first answered 24/05/2019 11:48:46 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	4558 label Biography information for Baroness Thornhill

1136415

	registered interest
	date	02/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Vitamins
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of (1) the safety, and (2) the effectiveness, of using IV vitamin drips and other related therapies offered by retail clinics.
	tabling member printed	Lord Birt
	uin	HL16865
	answer	answer is ministerial correction date of answer 10/07/2019 answer text <p>If retail clinics are intending to administer vitamin drips and other related therapies intravenously for a medicinal purpose then the products and associated advertising must be in compliance with all relevant aspects of medicines legislation which includes an assessment of the safety quality and efficacy for licensed medicines.</p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) is the United Kingdom body responsible for ensuring that medicines work and are acceptably safe.</p><p>Intravenous drips which are not intended for a medical purpose are not medicines and these products fall outside the MHRA’s jurisdiction.</p> answering member printed Baroness Blackwood of North Oxford question first answered 10/07/2019 15:27:10 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	2533 label Biography information for Lord Birt

1130247

	registered interest
	date	05/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Vaccination
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government, further to the Written Answers by Baroness Blackwood of North Oxford on 22 May (HL15599 and 15600), which innovative vaccination schedules have been introduced following the Joint Committee on Vaccination and Immunisation's advice, including when a dose has been removed from an established programme.
	tabling member printed	Baroness Masham of Ilton
	uin	HL16108
	answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) is the Government’s independent expert advisory body and its advice has always previously been followed.</p><p>The United Kingdom frequently adopts innovative immunisation schedules and we regularly change the vaccine schedule following the advice of the JCVI.</p><p>The JCVI advised that a two-dose schedule for the infant pneumococcal conjugate vaccine Prevenar13 is appropriate for the UK in place of the current three-dose schedule.</p><p>The JCVI’s advice was given full consideration, taking into account the potential public health implications, such as impact on cases of pneumococcal disease, before a decision was made to implement it. The evidence shows that two doses will sustain the results we have already seen. The decision is based on the excellent effectiveness of the vaccine and years of high uptake, which has helped to provide protection to the rest of the population and has successfully controlled many types of pneumococcal disease in this country.</p><p>We are confident that the world-class disease surveillance system we have in this country means our expert committee can closely monitor the impact of this change.</p> answering member printed Baroness Blackwood of North Oxford question first answered 18/06/2019 12:30:18 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	1850 label Biography information for Baroness Masham of Ilton

1131483

	registered interest
	date	11/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Vaccination
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what steps they are taking to increase the range of vaccination sources that could be provided in community pharmacies through the NHS.
	tabling member printed	Baroness Redfern
	uin	HL16277
	answer	answer is ministerial correction date of answer 25/06/2019 answer text <p>Vaccination is one of the world’s most clinically effective public health interventions. Community pharmacies already provide National Health Service flu vaccination. During the 2018/19 flu season 1,431,538 vaccinations were provided in community pharmacy.</p><p>NHS England and NHS Improvement are currently undertaking a review of all vaccinations and immunisations and community pharmacy is represented in that review.</p> answering member printed Baroness Barran question first answered 25/06/2019 14:32:43 answering member 4703 label Biography information for Baroness Barran
	tabling member	4551 label Biography information for Baroness Redfern

1127014

	registered interest
	date	15/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Tobacco: Retail Trade
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what is their assessment of the paper Impact of a ban on the open display of tobacco products in retail outlets on never smoking youth in the UK: findings from a repeat cross-sectional survey before, during and after implementation, published in the British Medical Journal in May; and whether they will consider the implications of those findings for other unhealthy commodity industries, including gambling.
	tabling member printed	The Lord Bishop of St Albans
	uin	HL15775
	answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>The Government keeps all such evidence on the impact of its policies under review, including the possible wider application of individual policies to other areas. The Government intends to conduct a formal post-implementation review of this legislation with a report due in spring 2020 and evidence of this nature will be looked at to assess the overall impact of legislation. There are no plans to extend the current ban on open display of tobacco products in retail outlets to other products.</p> answering member printed Baroness Blackwood of North Oxford question first answered 24/05/2019 11:48:27 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	4308 label Biography information for The Lord Bishop of St Albans

1137956

	registered interest
	date	09/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Speech and Language Therapy: Children
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether the Secretaries of State for Health and Social Care, Education, and Housing, Communities and Local Government have discussed, or plan to discuss the findings of the Children's Commissioner for England's report We need to talk: Access to speech and language therapy, published on 11 June.
	tabling member printed	Lord Ramsbotham
	uin	HL17055
	answer	answer is ministerial correction date of answer 17/07/2019 answer text <p>Colleagues across different Departments meet frequently to discuss a range of topics relating to child wellbeing. The Government recognises that speech, language and communication skills are a primary indicator of child wellbeing and will continue to provide strategic leadership across education, health and social care to narrow inequalities.</p><p> </p> answering member printed Baroness Blackwood of North Oxford question first answered 17/07/2019 14:09:03 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	3744 label Biography information for Lord Ramsbotham

1133055

	registered interest
	date	18/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Social Services
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 11 February (HL13173) which stated that the "Social Care Green Paper remains a priority for this Government", how they define priority in this instance; and what are the Department of Health and Social Care's other priorities.
	tabling member printed	Lord Pendry
	uin	HL16473
	answer	answer is ministerial correction date of answer 27/06/2019 answer text <p>Building a sustainable care and support system where people understand their responsibilities and can prepare for the future is a key priority for this Government. It is important that people know that the care they receive will be to a high standard and will help them maintain their independence and well-being.</p><p>The Department continues to work closely on the Green Paper. Minsters meet regularly with officials and ensure that other departments and key stakeholders are consulted regularly.</p><p>In line with the Government’s planning and performance framework process, the Department’s priorities are published online in the Single Departmental Plan.</p><p>The Department’s priorities for 2018/19 are that we will:</p><p>- keep people healthy to support economic productivity and sustainable public services;</p><p>- transform primary care, community, and social care to keep people living more independent, healthier lives for longer in their community;</p><p>- support the National Health Service to deliver high quality, safe and sustainable hospital care and secure the right workforce;</p><p>- support research and innovation to maximise health and economic productivity;</p><p>- ensure accountability of the health and care system to Parliament and the taxpayer, and create an efficient and effective Department;</p><p>- create value (reduced costs and growing income) by promoting better awareness and adoption of good commercial practice across the Department and our arm’s length bodies.</p><p>The Department’s 2019/20 Single Departmental Plan will be published in due course in line with the usual processes.</p> answering member printed Baroness Blackwood of North Oxford question first answered 27/06/2019 13:37:50 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	457 label Biography information for Lord Pendry

1130604

	registered interest
	date	06/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Shingles: Vaccination
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the case for encouraging people who are 60 years old and above who have not been vaccinated against shingles to receive a vaccination; and what steps they are taking to encourage the take-up of that vaccine amongst that cohort.
	tabling member printed	Baroness Featherstone
	uin	HL16148
	answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>The National Shingles Vaccination Programme, implemented in September 2013 is provided by general practices. The Joint Committee on Vaccination and Immunisation recommends the shingles vaccine for adults routinely at age 70 years with a phased catch up for those aged 71-79 years. The eligibility criteria change means that patients become eligible for the vaccine from their 70th and 78th birthdays, if not previously vaccinated, and can be offered the vaccine opportunistically all year round.</p><p>In support of this change, Public Health England (PHE) has updated the communication materials for both patients and healthcare professionals to better identify those who are eligible and emphasise the benefits to patients from the shingles vaccination. This includes guidance for those individuals who have missed the opportunity to receive the vaccine previously but who remain eligible, up to their 80th birthday.</p> answering member printed Baroness Blackwood of North Oxford question first answered 18/06/2019 12:29:15 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	1531 label Biography information for Baroness Featherstone